1948 के फार्मेसी अधिनियम के साथ फार्मेसियों के अनुपालन की जांच के लिए NSPC द्वारा तीन फार्मेसी निरीक्षकों की नियुक्ति की जाएगी।

The three district pharmacy officers who were chosen will soon receive appointment orders from the Nagaland State Pharmacy Council (NSPC) appointing them as pharmacy inspectors. Three inspectors will first be hired to inspect pharmacies for compliance with the Pharmaceutical Act…

एक अभिनव Stem Cell Robot जिसका UK MHR परीक्षण कर रहा है, जीवन रक्षक सेल उपचारों की पहुंच में क्रांति ला सकता है

The UK Medicines and Healthcare products Regulatory Agency is testing the CellQualia Intelligent Cell Processing System, a novel robotic robot that cultivates stem cells (MHRA). This robotic technology has the potential to offer patients with a variety of ailments safer…

Download Pharmacy Law & Ethics (E20-26T) Model Papers D. Pharma 2nd Year

Welcome to Pharmacy India, your dedicated hub for top-tier pharmaceutical education resources! 🌟 Dive into the intricacies of Pharmacy Law & Ethics with our E20-26T Model Papers tailored for D. Pharma 2nd Year. Elevate your exam preparation and deepen your understanding of crucial legal and ethical aspects with these meticulously crafted resources.

Download Biochemistry & Clinical Pathology (ER20-23T) Model Paper D. Pharma 2nd Year

Welcome to Pharmacy India, your premier destination for cutting-edge pharmaceutical education resources! 🌟 Embark on a journey through Biochemistry & Clinical Pathology with our ER20-23T Model Paper tailored for D. Pharma 2nd Year. Elevate your exam preparation and deepen your understanding of vital biochemical and clinical principles with these meticulously crafted resources.

Apply for Work from Home Regulatory Consultant / Sr Reg Consultant (CMC- API) at Syneos Health – B. Pharma/ M. Pharma/ Lifescience/ Ph. D

Syneos Health is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, seamlessly connecting our capabilities to add high-value insights to speed therapies to patients and provide practical value to help…

Merck gives an update from the phase 2 KeyVibe-002 trial of MK-7684A, a coformulation of vibostolimab with pembrolizumab, in patients with metastatic NSCLC who have already received treatment.

The open-label portion of the non-registrational phase 2 KeyVibe-002 trial received an update from Merck, also known as MSD outside of the United States and Canada. For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) who have…

Back to top

Registration Form


This will close in 0 seconds

WhatsApp Join Telegram